Correlation Between GlaxoSmithKline PLC and Koninklijke Vopak

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Koninklijke Vopak at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Koninklijke Vopak into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Koninklijke Vopak NV, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Koninklijke Vopak and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Koninklijke Vopak. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Koninklijke Vopak.

Diversification Opportunities for GlaxoSmithKline PLC and Koninklijke Vopak

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and Koninklijke is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Koninklijke Vopak NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Koninklijke Vopak and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Koninklijke Vopak. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Koninklijke Vopak has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Koninklijke Vopak go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Koninklijke Vopak

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Koninklijke Vopak. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.09 times less risky than Koninklijke Vopak. The stock trades about -0.3 of its potential returns per unit of risk. The Koninklijke Vopak NV is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  4,358  in Koninklijke Vopak NV on August 28, 2024 and sell it today you would earn a total of  84.00  from holding Koninklijke Vopak NV or generate 1.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Koninklijke Vopak NV

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Koninklijke Vopak 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Koninklijke Vopak NV are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain forward-looking signals, Koninklijke Vopak may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Koninklijke Vopak Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Koninklijke Vopak

The main advantage of trading using opposite GlaxoSmithKline PLC and Koninklijke Vopak positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Koninklijke Vopak can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Koninklijke Vopak will offset losses from the drop in Koninklijke Vopak's long position.
The idea behind GlaxoSmithKline PLC ADR and Koninklijke Vopak NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios